Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine as adjunct therapy for Bipolar I Disorder
NCT00107731Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of quetiapine in bipolar I disorder, sponsored by AstraZeneca. Started Apr 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00107731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107731.